Ilya Pharma selected for Sparks IPO Academy Class of 2024/2025
News
Open position: CFO
Ilya Pharma will present Poster with AMR data for ILP100 at US military medical partnering conference MHSRS August 26-29 August, Kissimmee, FL
Ilya Pharma will present new data in antimicrobial resistance (AMR) and the bacterial killing activity of ILP100 on multi-drug-resitant (MDR) pathogenic bacteria isolated from War victims in Ukraine.
New publication in American Journal of Physiology Gastrointestinal and Liver on the MOA and PoC for ILP100-Oral in multiple models of colitis
The work is funded by Ilya Pharma AB, Bio-X grant from STUNS in Uppsala and the Knut and Alice Wallenberg Foundation.
Open position part-time accounting assistant
The company is insourcing business administration.
Presentation of new data of antimicrobial effects on multi-drug resistant bacterial infections from Ukraine war victims
CXCL12-expressing Limosilactobacillus reuteri has clinically relevant antimicrobial effects of multidrug-resistant bacteria isolated from wounds of war victims in Ukraine Presented by Dr Andreas Fasth Poster ID 939